MariMed Inc. (MRMD)
OTCMKTS · Delayed Price · Currency is USD
0.1376
+0.0141 (11.42%)
Aug 28, 2025, 3:59 PM EDT
MariMed Market Cap
MariMed has a market cap or net worth of $48.49 million as of August 28, 2025. Its market cap has decreased by -45.79% in one year.
Market Cap
48.49M
Enterprise Value
142.30M
Revenue
157.16M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.14
Market Cap Chart
Since May 12, 2017, MariMed's market cap has increased from 25.70M to 48.49M, an increase of 88.68%. That is a compound annual growth rate of 7.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2025 | 48.49M | 9.76% |
| Dec 31, 2024 | 44.17M | -57.26% |
| Dec 29, 2023 | 103.36M | -14.51% |
| Dec 30, 2022 | 120.90M | -58.11% |
| Dec 31, 2021 | 288.61M | 101.45% |
| Dec 31, 2020 | 143.26M | 3.03% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 12, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 636.43M |
| Elite Pharmaceuticals | 594.22M |
| CytoDyn | 388.66M |
| Northwest Biotherapeutics | 357.21M |
| American Oncology Network | 357.05M |